REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Daehan New Pharm Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Daehan New Pharm Co.,Ltd. Profile Updated: November 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Daehan New Pharm Co., Ltd is a pharmaceutical company that offers a range of products and solutions in the pharmaceutical industry and operates in various segments.

Headquarters
904-3 Sangsin-Ri, Hyangnam-Myeon, Hwaseong-Si
Hwaseong; Gyeonggi;

Contact Details: Purchase the Daehan New Pharm Co.,Ltd. report to view the information.

Website: http://www.dhnp.co.kr

Basic Information
Total Employees:
Purchase the Daehan New Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Daehan New Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Daehan New Pharm Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Daehan New Pharm Co.,Ltd. report to view the information.
Incorporation Date:
October 20, 1984
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
34.89%
Purchase this report to view the information.
2.46%
Purchase this report to view the information.
0.73%
Subsidiaries
Astrazeneca Ab
Baverstock Gmbh
Caspian Sunrise
Company Performance
Financial values in the chart are available after Daehan New Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-1.92%▼
Total operating revenue
-2.05%▼
Operating profit (EBIT)
-17.3%▼
EBITDA
-12.9%▼
Net Profit (Loss) for the Period
-0.33%▼
Total assets
12.21%▲
Total equity
9.55%▲
Operating Profit Margin (ROS)
-1.95%▼
Net Profit Margin
0.17%▲
Return on Equity (ROE)
-0.89%▼
Debt to Equity Ratio
6.86%▲
Quick Ratio
-0.23%▼
Cash Ratio
-0.05%▼

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Whanin Pharmaceutical Co.,Ltd.
 
Kyongbo Pharmaceutical Co. Ltd.
Daihan Pharmaceutical Co.,Ltd.
 
Hyundai Pharmaceutical Co.,Ltd
Samchundang Pharm. Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo